0
0
Home

Interventional Radiology – Medical Devices Pipeline Assessment, 2020

Interventional Radiology which generates high quality image of tumor by performing simultaneous motion estimation and motion-compensated image reconstruction for cancer patients undergoing radiation therapy. GlobalData's Medical Devices sector report, “Interventional Radiology – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Interventional Radiology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Interventional Radiology Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Interventional Radiology under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Interventional Radiology pipeline products.

Review of Recent Developments in the segment / industry

The Interventional Radiology Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Interventional Radiology under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Interventional Radiology under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Interventional Radiology and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Interventional Radiology under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Accuray Inc

Actuality Medical, Inc. (Inactive)

Akesis LLC

Bendit Technologies Ltd

Biocompatibles UK Ltd

BrachyFoam LLC

BTG Ltd

Cornell University

CR Bard Inc

Creo Medical Ltd

Elekta AB

GYS Tech LLC

IMRIS, Inc.

Intelligent Ultrasound Ltd

Landauer Inc

MagnetTx Oncology Solutions Inc

Medical Device Investments, Inc.

Neutron Therapeutics Inc

Orfit Industries NV

Protonvda Inc

Quantitative Radiology Solutions LLC

Radiabeam Technologies LLC

Radiaction Ltd

RadiaDyne, LLC

Siemens Healthineers AG

SpectraCure AB

Standard Imaging Inc

Theralase Technologies Inc

University Health Network

University of California Los Angeles

University of Florida

University of South Florida

University of Texas Southwestern Medical Center

Varian Medical Systems Inc

Vivos Inc

XL Sci-Tech Inc

Xoft Inc

ZHealth Documentation LLC

Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 13

2.1 Interventional Radiology Overview 13

3 Products under Development 14

3.1 Interventional Radiology – Pipeline Products by Stage of Development 14

3.2 Interventional Radiology – Pipeline Products by Territory 15

3.3 Interventional Radiology – Pipeline Products by Regulatory Path 16

3.4 Interventional Radiology – Pipeline Products by Estimated Approval Date 17

3.5 Interventional Radiology – Ongoing Clinical Trials 18

4 Interventional Radiology – Pipeline Products under Development by Companies 19

4.1 Interventional Radiology Companies – Pipeline Products by Stage of Development 19

4.2 Interventional Radiology – Pipeline Products by Stage of Development 21

5 Interventional Radiology Companies and Product Overview 23

5.1 Accuray Inc Company Overview 23

5.1.1 Accuray Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Actuality Medical, Inc. (Inactive) Company Overview 24

5.2.1 Actuality Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Akesis LLC Company Overview 25

5.3.1 Akesis LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Bendit Technologies Ltd Company Overview 27

5.4.1 Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Biocompatibles UK Ltd Company Overview 29

5.5.1 Biocompatibles UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 BrachyFoam LLC Company Overview 32

5.6.1 BrachyFoam LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 BTG Ltd Company Overview 33

5.7.1 BTG Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 Cornell University Company Overview 35

5.8.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 35

5.9 CR Bard Inc Company Overview 37

5.9.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.10 Creo Medical Ltd Company Overview 39

5.10.1 Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 Elekta AB Company Overview 40

5.11.1 Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40

5.12 GYS Tech LLC Company Overview 45

5.12.1 GYS Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.13 IMRIS, Inc. Company Overview 47

5.13.1 IMRIS, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.14 Intelligent Ultrasound Ltd Company Overview 48

5.14.1 Intelligent Ultrasound Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.15 Landauer Inc Company Overview 51

5.15.1 Landauer Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.16 MagnetTx Oncology Solutions Inc Company Overview 52

5.16.1 MagnetTx Oncology Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.17 Medical Device Investments, Inc. Company Overview 53

5.17.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

5.18 Neutron Therapeutics Inc Company Overview 54

5.18.1 Neutron Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.19 Orfit Industries NV Company Overview 55

5.19.1 Orfit Industries NV Pipeline Products & Ongoing Clinical Trials Overview 55

5.20 Protonvda Inc Company Overview 56

5.20.1 Protonvda Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.21 Quantitative Radiology Solutions LLC Company Overview 58

5.21.1 Quantitative Radiology Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.22 Radiabeam Technologies LLC Company Overview 59

5.22.1 Radiabeam Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.23 Radiaction Ltd Company Overview 60

5.23.1 Radiaction Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.24 RadiaDyne, LLC Company Overview 61

5.24.1 RadiaDyne, LLC Pipeline Products & Ongoing Clinical Trials Overview 61

5.25 Siemens Healthineers AG Company Overview 62

5.25.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 62

5.26 SpectraCure AB Company Overview 63

5.26.1 SpectraCure AB Pipeline Products & Ongoing Clinical Trials Overview 63

5.27 Standard Imaging Inc Company Overview 67

5.27.1 Standard Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.28 Theralase Technologies Inc Company Overview 68

5.28.1 Theralase Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.29 University Health Network Company Overview 74

5.29.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 74

5.30 University of California Los Angeles Company Overview 76

5.30.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 76

5.31 University of Florida Company Overview 77

5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 77

5.32 University of South Florida Company Overview 78

5.32.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 78

5.33 University of Texas Southwestern Medical Center Company Overview 79

5.33.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

5.34 Varian Medical Systems Inc Company Overview 82

5.34.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.35 Vivos Inc Company Overview 84

5.35.1 Vivos Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.36 XL Sci-Tech Inc Company Overview 87

5.36.1 XL Sci-Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.37 Xoft Inc Company Overview 88

5.37.1 Xoft Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.38 ZHealth Documentation LLC Company Overview 95

5.38.1 ZHealth Documentation LLC Pipeline Products & Ongoing Clinical Trials Overview 95

6 Interventional Radiology- Recent Developments 96

6.1 Jul 14, 2020: IntraOp and OSU announce collaboration in FLASH 96

6.2 Jul 14, 2020: Cardiac CT can double as osteoporosis test 96

6.3 Jun 30, 2020: Theralase announces management information circular and annual general meeting postponement due to COVID-19 97

6.4 Jun 30, 2020: Brain iron accumulation linked to cognitive decline in Alzheimer’s Patients 97

6.5 Jun 30, 2020: 3D ultrasound enables accurate, noninvasive measurements of blood flow 98

6.6 Jun 25, 2020: RSNA launches international COVID-19 open radiology database 99

6.7 Jun 15, 2020: House-call model tapping interventional radiology improves outcomes and access to care 100

6.8 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 101

6.9 May 06, 2020: New ACR Guidance can help radiology facilities resume non-urgent care 102

6.10 Apr 01, 2020: China uses self-developed carbon ion facility in cancer treatment 102

6.11 Mar 31, 2020: iCAD announces new credit facility with Bridge Bank, increasing operational flexibility 102

6.12 Mar 11, 2020: Quebec selects Varian to increase access to advanced cancer care 102

6.13 Feb 27, 2020: iCAD reports fourth quarter and full-year 2019 financial results 103

6.14 Feb 25, 2020: Queensland’s Royal Brisbane and Women's Hospital selects RayStation from RaySearch to plan for Varian treatment machines 105

6.15 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 106

6.16 Feb 20, 2020: Elekta: Interim report May-January 2019/20 107

6.17 Feb 17, 2020: First clinic in South America goes live with RayStation treatment planning for Accuray's Radixact System 108

6.18 Feb 14, 2020: RaySearch Laboratories: Year-end report 1 January – 31 December 2019 108

6.19 Feb 12, 2020: Elekta appoints new Head of Region North and Central America 109

6.20 Feb 11, 2020: First brain tumor treated with Xoft IORT in the United States 109

6.21 Feb 11, 2020: Lübeck University Hospital buys VibroSense Meter II after completing pilot study 110

6.22 Feb 11, 2020: Varex announces renewed pricing agreement with Canon Medical Systems 111

6.23 Feb 11, 2020: Isoray announces second quarter fiscal 2020 financial results 111

6.24 Feb 05, 2020: Isoray collaborates with MIM Software to deliver an advanced treatment solution for recurrent head and neck cancers 112

6.25 Feb 05, 2020: Eckert & Ziegler to open up US-production site for Yttrium-90 112

6.26 Feb 05, 2020: Studies support use of the accuray TomoTherapy system for advanced rectal cancer to improve treatment efficacy and reduce side effects 113

6.27 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 115

6.28 Jan 30, 2020: Switzerland's Hopital Riviera-Chablais treats its first patient with Elekta Unity MR-Linac 117

6.29 Jan 29, 2020: Varian reports results for first quarter of fiscal year 2020 118

6.30 Jan 28, 2020: Accuray reports fiscal 2020 second quarter financial results 119

6.31 Jan 28, 2020: FDA reclassifies certain medical image analyzers 120

6.32 Jan 27, 2020: GammaTile therapy cleared for newly diagnosed malignant tumours 121

6.33 Jan 27, 2020: iCAD Showcases Technology for Cancer “Discovery to Recovery” including ProFound AI Platform and Xoft System at Arab Health 2020 in Dubai 121

6.34 Jan 27, 2020: Theralase granted US patent for multiwavelength photodynamic therapy 123

6.35 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 123

6.36 Jan 23, 2020: Vulnerability disclosure regarding GE Healthcare monitoring products 124

6.37 Jan 23, 2020: GE Healthcare to move as many as 250 jobs from Wisconsin 125

6.38 Jan 20, 2020: Institut Jules Bordet invests in Elekta’s latest cancer treatment technology 125

6.39 Jan 15, 2020: China's HEDY Group acquires 10 Elekta cancer treatment systems 126

6.40 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 126

6.41 Jan 14, 2020: RSNA 2019 Sees Possibilities in AI 127

6.42 Jan 13, 2020: HFAH acquires advanced technology for cancer treatment 128

6.43 Jan 13, 2020: Study reveals radiotherapy can cure bladder cancer 128

6.44 Jan 13, 2020: iCAD appoints Nathaniel Dalton to its board of directors 129

6.45 Jan 13, 2020: Accuray to discuss revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare Conference 129

6.46 Jan 13, 2020: ViewRay announces preliminary fourth quarter and full year 2019 results 130

6.47 Jan 09, 2020: IntraOp and Alliant Dermatology bring electron beam therapy to skin cancer patients in Florida 130

6.48 Jan 09, 2020: Penn Medicine shows giving entire course of radiation treatment in less than a second is feasible 131

6.49 Jan 08, 2020: Accuray CyberKnife System provides excellent disease control for men with recurrent prostate cancer, a medical condition with few viable treatment options 132

6.50 Dec 31, 2019: Belgium customers select C-RAD’s innovative SIGRT solution 133

6.51 Dec 23, 2019: RayStation 9B release adds support for chemotherapy planning 133

6.52 Dec 20, 2019: First patient treatments delivered with RayStation and Hitachi proton therapy system at Sibely Memorial Hospital 134

6.53 Dec 20, 2019: The Medical Group of South Florida acquires Halcyon System for Image-Guided Cancer Treatments 135

6.54 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 135

6.55 Dec 19, 2019: Michigan Community Hospital begins patient treatments with ViewRay's MRIdian Linac 135

6.56 Dec 18, 2019: Guerbet David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy 136

6.57 Dec 17, 2019: First MRIdian MRI-guided radiotherapy treatments begin in the United Kingdom 137

6.58 Dec 17, 2019: ControlRad announces additions to leadership team 137

6.59 Dec 16, 2019: FDA approves diffusion-weighted images for Elekta Unity, expanding options for assessment during therapy 139

6.60 Dec 12, 2019: Timpanogos Cancer Services First in Utah to Offer Precise and Accurate Radiation Treatments with the Accuray Radixact System 139

6.61 Dec 11, 2019: GenesisCare launches MRIdian radiotherapy in the UK 140

6.62 Dec 11, 2019: A boost of €4,1M for joint proton therapy research TU Delft, Erasmus MC and LUMC 140

6.63 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 141

6.64 Dec 09, 2019: Townsville Hospital treats first Australian patient with Elekta Unity MR-Linac, a transformative approach to precision radiation therapy 142

6.65 Dec 05, 2019: RaySearch will expand to new headquarters in 2021 143

6.66 Dec 05, 2019: Bayer helps support imaging access in developing countries through RAD-AID donation 144

6.67 Dec 05, 2019: Long-term study finds faster breast cancer radiation treatment as effective as longer course 144

6.68 Dec 05, 2019: Funding secured for public patients at GenesisCare Shepparton 146

6.69 Dec 03, 2019: Varian further expands access to care in Africa to address growing cancer burden 146

6.70 Dec 03, 2019: 21st Century Oncology sets a new standard in cancer care with new State-Of-The-Art Radiation Systems 147

6.71 Dec 03, 2019: Leave to Appeal in patent dispute over C-RAD’s entitlement to patents granted 147

6.72 Dec 03, 2019: One dose of radiotherapy as effective as five doses for cancer in the spine 148

6.73 Dec 02, 2019: Evolving role of artificial intelligence in radiological imaging 149

6.74 Dec 01, 2019: ScriptSender partners with EvoHealth for stronger physician collaboration 150

6.75 Nov 29, 2019: RaySearch to demonstrate machine learning at RSNA 2019 150

6.76 Nov 29, 2019: Theralase releases third quarter 2019 financial results and company update 151

6.77 Nov 28, 2019: Elekta: Interim report, May–October 2019/20 153

6.78 Nov 28, 2019: Financial support to SAGA Heavy Ion Medical Accelerator in Tosu Project 153

6.79 Nov 27, 2019: Theralase researchers receive recognition for recent scientific publications 154

6.80 Nov 27, 2019: Dr. Michelle Le Beau named to Varian board of directors 155

6.81 Nov 26, 2019: Varian establishes direct operation in Kenya 155

6.82 Nov 25, 2019: New Leading Edge Technology for Cancer Treatment 156

6.83 Nov 25, 2019: MRI reveals brain damage in Obese teens 157

6.84 Nov 22, 2019: Varian updates GAAP results for fourth quarter and full fiscal year 2019 158

6.85 Nov 22, 2019: C-RAD has appointed Henrik Bergentoft as new CFO 158

6.86 Nov 22, 2019: NRG Oncology trial shows that breast cancer recurrence after lumpectomy and radiation is treatable with localized radiation without mastectomy 158

6.87 Nov 21, 2019: Care Partners cancer symptom outcomes study now enrolling patients 159

6.88 Nov 20, 2019: Ensembling improves machine learning model performance 159

6.89 Nov 18, 2019: First cancer patient treated with Varian ProBeam Compact Proton Therapy System at treatment center in Florida 161

6.90 Nov 18, 2019: RayStation chosen for state-of-the-art proton and heavy ion center in Shanghai 161

6.91 Nov 18, 2019: C-RAD opens a new office in Shanghai, China 162

6.92 Nov 18, 2019: Scandinavian ChemoTech and its CEO Mohan Frick participates and presents at the emerging Medtech Summit in California, USA 162

6.93 Nov 15, 2019: Elekta announces preliminary Q2 results and updated guidance for fiscal year 2019/20 163

6.94 Nov 15, 2019: Next-Generation imaging key to fighting advanced Prostate Cancer 163

6.95 Nov 14, 2019: Uppsala University Hospital first in Sweden to treat patient with Elekta Unity cancer treatment system 165

6.96 Nov 14, 2019: Iba business update – third quarter 2019 165

6.97 Nov 14, 2019: RaySearch Laboratories : Interim report 1 January – 30 September 2019 166

6.98 Nov 13, 2019: Canon Medical supports expert forums on advancements in imaging technology at RSNA 2019 167

6.99 Nov 12, 2019: ViewRay reports third quarter 2019 results 167

6.100 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 168

6.101 Nov 08, 2019: C-RAD comments on the decision on penalty from the Disciplinary Committee at Nasdaq Stockholm 169

6.102 Nov 07, 2019: Appointment of Independent Director to the Board Of Sonic Healthcare 170

6.103 Nov 05, 2019: Sacro Cuore-Don Calabria Cancer Care Center treats its first patient with Elekta Unity MR-Linac 170

6.104 Nov 05, 2019: RaySearch releases preliminary results for the third quarter 2019 171

6.105 Nov 04, 2019: Cancer Research UK announces research network for radiotherapy 172

6.106 Nov 04, 2019: Leeds scientists lead next generation of radiotherapy treatments 172

6.107 Nov 04, 2019: UCLH and UCL receive major investment to support next-generation radiotherapy research 175

6.108 Nov 01, 2019: C-RAD announces changes to the group management team 175

6.109 Oct 31, 2019: Theralase announces leadership transition 176

6.110 Oct 30, 2019: Icon Group expands cancer care capabilities with purchase of Varian Adaptive Therapy Solution 176

6.111 Oct 30, 2019: iCAD reports financial and operating results for the third quarter and nine months ended September 30, 2019 177

6.112 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 180

6.113 Oct 29, 2019: Holmium-166 Scout (QuiremScout™) has shown superior predictive value when compared to Technetium-99m-macroaggregated Albumin during SIRT work-up 182

6.114 Oct 29, 2019: Accuray reports fiscal 2020 first quarter financial results 183

6.115 Oct 29, 2019: Varian names Anshul Maheshwari vice president investor relations 184

6.116 Oct 28, 2019: First Asia-Pacific Hospital Treats Patients With RayStation and Radixact 184

6.117 Oct 28, 2019: Covera Health expands strategic business team, supporting commercial growth 185

6.118 Oct 25, 2019: C-RAD: Interim report January-September 2019 186

6.119 Oct 24, 2019: Invitation to attend a live Elekta Unity treatment at University Hospital Tübingen 187

6.120 Oct 24, 2019: European Symposium to advance adoption of MRI-Guided Radiation Therapy 187

6.121 Oct 24, 2019: RADiant to exhibit at the 2019 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL 189

6.122 Oct 24, 2019: Varian ProBeam 360 System selected by The Ohio State University for New Proton Therapy Center 189

6.123 Oct 23, 2019: Varian ProBeam 360 Proton Therapy System selected by Penn Medicine for use in second treatment center 189

6.124 Oct 23, 2019: Elekta wins the Technology Services Industry Association STAR award 190

6.125 Oct 23, 2019: Varian reports results for fourth quarter and full fiscal year 2019 191

6.126 Oct 23, 2019: Varian appoints new president of interventional oncology solutions and new Chief Financial Officer 192

6.127 Oct 22, 2019: Researchers awarded 2019 Canon Medical Systems RSNA research grants 193

6.128 Oct 21, 2019: Accuray appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer 194

6.129 Oct 17, 2019: Elekta Unity MR-Linac receives Innovation Award from the Institute of Physics 194

6.130 Oct 17, 2019: MD Anderson and Varian partner to optimize radiation oncology treatment 195

6.131 Oct 15, 2019: ViewRay announces preliminary third quarter 2019 results and details of upcoming conference call 195

6.132 Oct 14, 2019: Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center achieve significant milestone in research of FLASH Therapy 196

6.133 Oct 14, 2019: Canon Medical to launch new division in Dubai, UAE 196

6.134 Oct 11, 2019: Bayer and Sensyne Health team up for AI-enabled imaging 197

6.135 Oct 11, 2019: UCSF launches Artificial Intelligence center to Advance Medical Imaging 197

6.136 Oct 07, 2019: Patient treatments with ViewRay's MRIdian Linac begin in New England 199

6.137 Oct 04, 2019: RaySearch has received new regulatory clearance for RayStation in China 199

6.138 Oct 01, 2019: IBA receives down payment for Proteus PLUS contract in Shenzhen, China 200

6.139 Oct 01, 2019: El Camino Health first on West Coast to offer new targeted therapy for recurrent brain tumors 200

6.140 Sep 27, 2019: Xstrahl spotlights RADiant Dual Modality Treatment System at Texas Dermatology 2019 201

6.141 Sep 26, 2019: Multiple abstracts presented at ASTRO demonstrate the technical capabilities and clinical utility of the Elekta Unity MR-linac System 201

6.142 Sep 26, 2019: RaySearch expands to a new major market with distribution agreement for Russia 202

6.143 Sep 25, 2019: Xstrahl spotlights new RADiant Treatment System at AOCD 2019 203

6.144 Sep 23, 2019: Varian U.S. Tariff exclusion request granted for Radiotherapy ystem components 203

6.145 Sep 19, 2019: Xstrahl spotlights new RADiant treatment system at Calderm 2019 203

6.146 Sep 19, 2019: Brigham Radiation Oncologists present findings at ASTRO 2019 204

6.147 Sep 17, 2019: University Hospital Salzburg selects IntraOp Mobetron 206

6.148 Sep 17, 2019: Data published in The Lancet Oncology suggest Cyberknife prostate patients experienced lower levels of acute genitourinary toxicity (grade 2 or higher) than patients treated on a conventional linear accelerator 206

6.149 Sep 17, 2019: Targeted radiotherapy technique could cut treatment time from two months to two weeks 207

6.150 Sep 16, 2019: Penn State Health enters into master purchase agreement with ViewRay for MRIdian Systems 209

6.151 Sep 16, 2019: iCAD exhibiting new updates and enhanced Xoft platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer 209

6.152 Sep 16, 2019: China announces Tariff Exclusion for Medical Linear Accelerators 210

6.153 Sep 16, 2019: Varian names Chief Medical Officer for Interventional Oncology 210

6.154 Sep 16, 2019: NRG Oncology trial shows no difference in pain response between stereotactic body radiotherapy and conventional radiotherapy for patients with spinal metastases 211

6.155 Sep 16, 2019: Pre-salvage RT PSA is predictive of hormone therapy benefit with salvage RT for men with recurrent prostate cancer on NRG Oncology trial 211

6.156 Sep 16, 2019: Reduced-dose intensity-modulated radiotherapy with cisplatin meets predetermined benchmarks for progression-free survival and swallowing-related quality of life for oropharyngeal cancer 212

6.157 Sep 15, 2019: Akesis previews next-generation Galaxy SRS and new LINAC platform at ASTRO 213

6.158 Sep 15, 2019: Radiation therapy effective against deadly heart rhythm 214

6.159 Sep 13, 2019: Xstrahl spotlights full range of x-ray therapy and radiation research systems at ASTRO 2019 215

6.160 Sep 12, 2019: Sun Nuclear presents portfolio of independent QA solutions at ASTRO 2019 215

6.161 Sep 12, 2019: ViewRay announces collaboration with Stanford Health Care 216

6.162 Sep 12, 2019: Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors 216

6.163 Sep 11, 2019: Varian expects to benefit from linear accelerator tariff exclusion in China 217

6.164 Sep 10, 2019: Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact System 217

6.165 Sep 10, 2019: Leading radiation oncology meeting to feature unique capabilities and compelling patient outcomes with ViewRay's MRIdian 218

6.166 Sep 10, 2019: Isoray To Spotlight Cesium-131 Advances in Treating Hard to Treat Cancers at the American Society for Radiation Oncology Annual Meeting 219

6.167 Sep 10, 2019: Varian-equipped New York Proton Therapy Center Treats First Patients 219

6.168 Sep 06, 2019: Koneksa Health Announces Poster Presentation at ASCO Quality Care Symposium 220

6.169 Sep 04, 2019: Accuray to Host ASTRO Investor Meeting on September 16, 2019 220

6.170 Sep 04, 2019: New mathematical model can improve radiation therapy of brain tumours 221

6.171 Sep 04, 2019: New guideline clarifies role of radiation therapy in pancreatic cancer treatment 221

6.172 Sep 03, 2019: Elekta to highlight Precision Radiation Medicine solutions that improve patient outcomes at ASTRO Annual Meeting 223

6.173 Sep 03, 2019: RADiant treatments commence at leading Texas dermatology center 223

6.174 Aug 30, 2019: C-RAD: Interim report January-June 2019 224

6.175 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 225

6.176 Aug 29, 2019: Theralase releases second quarter 2019 financial results and company update 226

6.177 Aug 28, 2019: Cyclotron for Varian ProBeam Compact Proton Therapy System installed at Sylvester Comprehensive Cancer Center 228

6.178 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 228

6.179 Aug 26, 2019: GT Medical Technologies to be honored with an AZBio Fast Lane Award 228

6.180 Aug 26, 2019: Xstrahl launches the new SARRP beamline for Proton, Photon, Carbon and Flash pre-clinical experiments 230

6.181 Aug 22, 2019: Elekta: Interim report, May–July 2019/20 230

6.182 Aug 22, 2019: IBA reports half year results for 2019 231

6.183 Aug 22, 2019: RSNA announces new global learning centers program 232

6.184 Aug 22, 2019: Accuray: Changes in Senior Vice President, Chief Commercial Officer 233

6.185 Aug 21, 2019: Froedtert & the Medical College of Wisconsin Cancer Network is first in the world to treat cancer patient using the Accuray Radixact System with Synchrony Motion Tracking and Correction Technology 234

6.186 Aug 21, 2019: Dr. Phil Febbo named to Varian Board of Directors 235

6.187 Aug 20, 2019: RaySearch Laboratories announces interim report January – June 2019 235

6.188 Aug 20, 2019: Sonic Healthcare announces financial results for the year ended 30 June 2019 236

6.189 Aug 19, 2019: ViewRay announces results of the first prospective clinical trial on MR-guided radiation treatment for prostate cancer without implanted markers 237

6.190 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 237

6.191 Aug 16, 2019: Sunnybrook Health Sciences Centre treats its first patient with Elekta Unity MR-Linac 238

6.192 Aug 15, 2019: GT Medical Technologies announces completion of first case in Arizona to use GammaTile Therapy 238

6.193 Aug 15, 2019: Accuray reports fourth quarter and fiscal 2019 financial results 239

6.194 Aug 14, 2019: Heidelberg University Hospital treats first patient using carbon ion therapy with RayStation 241

6.195 Aug 14, 2019: SpectraCure's new generation P18 241

6.196 Aug 14, 2019: Geisinger recognized as Radiology Center of Excellence by Covera Health 241

6.197 Aug 13, 2019: Efficacy of Isoray’s Cesium Blu showcased in recent studies 242

6.198 Aug 12, 2019: Mevion and C-RAD release integration for improved treatment quality in proton therapy 243

6.199 Aug 12, 2019: C-RAD and Mevion release integration for improved treatment quality in proton therapy 243

6.200 Aug 08, 2019: ViewRay reports second quarter 2019 results 244

6.201 Aug 08, 2019: RSNA and ACR to collaborate on landmark medical 3d printing registry 245

6.202 Aug 05, 2019: Second clinical study on Elekta MR-Linac adds to evidence base for MR-guided radiotherapy 246

6.203 Aug 05, 2019: IBA signs contract to install Cyclone 70 system in South Korea 247

6.204 Aug 05, 2019: Varian announces Immaterial Impact of newly proposed Tariffs 247

6.205 Aug 01, 2019: iCAD reports second quarter 2019 financial results 247

6.206 Jul 31, 2019: Ten years ago since first order of RayStation treatment planning system 249

6.207 Jul 30, 2019: HKSH Medical Group brings precision radiation medicine to cancer patients in Asia with Elekta Unity MR-Linac 250

6.208 Jul 30, 2019: GenesisCare to acquire nine Elekta Unity systems for advanced cancer treatment 251

6.209 Jul 30, 2019: McGill University Health Centre newest clinical study site for phase II non-muscle invasive bladder cancer clinical study 251

6.210 Jul 30, 2019: Ad­juvant ra­dio­ther­apy may be be­ne­fi­cial in treat­ing loc­ally ad­vanced pro­state can­cer 252

7 Appendix 254

7.1 Methodology 254

7.2 About GlobalData 257

7.3 Contact Us 257

7.4 Disclaimer 257

List of Tables

Table 1: Interventional Radiology – Pipeline Products by Stage of Development 14

Table 2: Interventional Radiology – Pipeline Products by Territory 15

Table 3: Interventional Radiology – Pipeline Products by Regulatory Path 16

Table 4: Interventional Radiology – Pipeline Products by Estimated Approval Date 17

Table 5: Interventional Radiology – Ongoing Clinical Trials 18

Table 6: Interventional Radiology Companies – Pipeline Products by Stage of Development 19

Table 7: Interventional Radiology – Pipeline Products by Stage of Development 21

Table 8: Accuray Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 11: Actuality Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Table 14: Akesis LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Table 19: Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Table 22: Biocompatibles UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Table 27: BrachyFoam LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Table 30: BTG Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Table 37: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 35

Table 42: CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Table 49: Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 52: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 40

Table 62: GYS Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 45

Table 67: IMRIS, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 70: Intelligent Ultrasound Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Table 75: Landauer Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Table 78: MagnetTx Oncology Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Table 81: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

Table 84: Neutron Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 87: Orfit Industries NV Pipeline Products & Ongoing Clinical Trials Overview 55

Table 90: Protonvda Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Table 95: Quantitative Radiology Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 58

Table 98: Radiabeam Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Table 101: Radiaction Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Table 104: RadiaDyne, LLC Pipeline Products & Ongoing Clinical Trials Overview 61

Table 107: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 62

Table 110: SpectraCure AB Pipeline Products & Ongoing Clinical Trials Overview 63

Table 118: Standard Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Table 121: Theralase Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Table 131: University Health Network Pipeline Products & Ongoing Clinical Trials Overview 74

Table 136: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 76

Table 139: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 77

Table 142: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 78

Table 145: University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

Table 152: Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 82

Table 157: Vivos Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Table 164: XL Sci-Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Table 167: Xoft Inc Pipeline Products & Ongoing Clinical Trials Overview 88

Table 178: ZHealth Documentation LLC Pipeline Products & Ongoing Clinical Trials Overview 95

Table 181: Glossary 256

List of Figures

Figure 1: Interventional Radiology – Pipeline Products by Stage of Development 14

Figure 2: Interventional Radiology – Pipeline Products by Territory 15

Figure 3: Interventional Radiology – Pipeline Products by Regulatory Path 16

Figure 4: Interventional Radiology – Pipeline Products by Estimated Approval Date 17

Figure 5: Interventional Radiology – Ongoing Clinical Trials 18

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports